Polo Biology Global Group Corporation Announces New Director, Chief Financial
Officer and Corporate Secretary

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/

VANCOUVER, May 28 /CNW/ - Polo Biology Global Group Corporation ("Polo Biology" or the "Company") announced today the appointment of Ming (Barry) Sheng as its corporate secretary effective May 15, 2010 and Xiao Qin (Mary) Ma as director and chief financial officer ("CFO") both effective June 1, 2010. The change in positions was proposed and supported by management and the board.

Ms. Ma is an experienced corporate executive having served Chinese companies in a financial advisory capacity since 1998, and a current director and corporate secretary of Symax Lift (Holding) Ltd. (TSXV:SYL). Ms. Ma has been involved in various going public transactions in the Canadian capital markets since 2007. Amongst other positions held by Ms. Ma, she was the Financial Controller of Zongshen PEM Power Systems Inc. (TSX:ZPP) from April 2005 to October 2007; Project Manager of Zongshen Industrial Group Co., Ltd. from May 2004 to March 2005; Financial Controller of Chongqing Lear Changan Interior Co., Ltd. from November 2003 to March 2004; and CFO of Chongqing Skyman Industrial Group Co., Ltd. from September 1998 to October 2003. Ms. Ma holds the Canadian Certified General Accountants designation, and is a member of the Association of Chartered Certified Accountants in the United Kingdom and the Chinese Institute of Certified Public Accountants in China.

Mr. Sheng is currently the President and CEO of MSJL Consulting and Management Limited, a Canadian company that provides management, investor relation and financial consulting services to Chinese companies listed on the TSX and TSX Venture Exchange. Mr. Sheng holds a Bachelor of Commerce from the University of British Columbia and is experienced with publicly listed companies based in China.

In addition to his new role of corporate secretary, Mr. Sheng will retain his investor relations responsibilities with the Company. Ms. Ma succeeds Mr. Fodie who will step down as CFO of the Company on May 31, 2010. Following these appointments, the Board of Directors will consist of six members being Li (Polo) Wu, Qing (Paul) Wu, Jie (Miranda) Liu, Xiao Qing (Mary) Ma, Jeff Zheng and John Morita, with Mr. Zheng and Mr. Morita being independent directors.

About Polo Biology Global Group Corporation

The Company, through its operating subsidiaries in China, develops, manufactures and distributes health supplements, personal and homecare products across China under the Polo brand. The Company currently distributes its products through Polo Biology Science Park Co., Ltd., which manages a network of retail outlets operated by its franchisees.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information: Paul Wu, Chief Executive Officer, Polo Biology Global Group Corporation, Telephone: [phone], E-mail: [email protected]; or Ming (Barry) Sheng, Investor Relations, Polo Biology Global Group Corporation, Tel: [phone], Email: [email protected]